Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDInari Medical, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.16 | -$0.15 | -$0.16 |
| Q2 2024 | 2 | -$0.20 | -$0.19 | -$0.19 |
| Q3 2024 | 8 | -$0.12 | -$0.11 | -$0.12 |
| Q4 2024 | 10 | -$0.25 | $0.04 | -$0.04 |
| Q1 2025 | 6 | -$0.17 | $0.02 | -$0.04 |
| Q2 2025 | 5 | -$0.02 | -$0.02 | -$0.02 |
| Q3 2025 | 5 | $0.02 | $0.02 | $0.02 |
| Q4 2025 | 5 | $0.01 | $0.01 | $0.01 |
| Q1 2026 | 2 | -$0.01 | -$0.01 | -$0.01 |
| Q2 2026 | 2 | -$0.08 | -$0.08 | -$0.08 |
| Q3 2026 | 2 | -$0.10 | -$0.10 | -$0.10 |
| Q4 2026 | 2 | -$0.19 | -$0.18 | -$0.18 |
Inari Medical, Inc. Earnings Date And Information
Inari Medical, Inc. last posted its earnings results on Monday, October 28th, 2024. The company reported $-0.13 earnings per share for the quarter, missing analysts' consensus estimates of $-0.12 by $0.01. The company had revenue of 153.39 M for the quarter and had revenue of 493.63 M for the year. Inari Medical, Inc. has generated $0 earnings per share over the last year ($-0.0288 diluted earnings per share) and currently has a price-to-earnings ratio of -39.34. Inari Medical, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Inari Medical, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/28/2024 | Q3 2024 | -$0.12 | -$0.31 | -0.19 | $150.69 M | $153.39 M |
| 07/30/2024 | Q2 2024 | -$0.16 | -$0.54 | -0.38 | $143.79 M | $145.82 M |
| 04/30/2024 | Q1 2024 | -$0.42 | $143.19 M | |||
| 02/28/2024 | Q4 2023 | -$0.08 | $132.09 M | |||
| 11/01/2023 | Q3 2023 | $0.00 | $0.06 | 0.06 | $121.92 M | $126.37 M |
| 08/02/2023 | Q2 2023 | -$0.13 | $0.04 | 0.17 | $116.67 M | $119.01 M |
| 05/03/2023 | Q1 2023 | -$0.23 | -$0.04 | 0.19 | $116.17 M | |
| 02/27/2023 | Q4 2022 | -$0.17 | -$0.11 | 0.06 | $107.77 M | |
| 11/02/2022 | Q3 2022 | -$0.24 | -$0.19 | 0.05 | $90.83 M | $96.20 M |
| 08/03/2022 | Q2 2022 | -$0.23 | -$0.19 | 0.04 | $87.80 M | $92.74 M |
| 05/04/2022 | Q1 2022 | -$0.08 | -$0.06 | 0.02 | $86.75 M | |
| 02/23/2022 | Q4 2021 | $0.03 | $0.02 | -0.01 | $83.22 M | |
| 11/09/2021 | Q3 2021 | -$0.11 | -$0.06 | 0.05 | $63.04 M | $72.92 M |
| 08/10/2021 | Q2 2021 | $0.08 | $0.08 | 0 | $59.65 M | $63.45 M |
| 05/11/2021 | Q1 2021 | $0.05 | $0.15 | 0.1 | $57.40 M | |
| 03/09/2021 | Q4 2020 | $0.01 | $0.14 | 0.13 | $48.61 M | |
| 11/12/2020 | Q3 2020 | $0.02 | $0.13 | 0.11 | $26.53 M | $38.72 M |
| 08/11/2020 | Q2 2020 | -$0.17 | -$0.16 | 0.01 | $12.97 M | $25.39 M |
| 03/30/2020 | Q1 2020 | $0.09 | $26.95 M | |||
| 12/30/2019 | Q4 2019 | $0.01 | $19.89 M |
Inari Medical, Inc. Earnings: FAQ's
When is Inari Medical, Inc.'s earnings date?
Inari Medical, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
How can I listen to Inari Medical, Inc.'s earnings conference
call?
The conference call for Inari Medical, Inc.'s latest earnings report can be listened to online.
How can I read Inari Medical, Inc.'s conference call transcript?
The conference call transcript for Inari Medical, Inc.'s latest earnings report can be read online.
How much revenue does Inari Medical, Inc. generate each year?
Inari Medical, Inc. (:NARI) has a recorded annual revenue of $493.63 M.
How much profit does Inari Medical, Inc. generate each year?
Inari Medical, Inc. (:NARI) has a recorded net income of $493.63 M. Inari Medical, Inc. has generated $-0.0288 earnings per share over the last four quarters.
What is Inari Medical, Inc.'s price-to-earnings ratio?
Inari Medical, Inc. (:NARI) has a price-to-earnings ratio of -39.34 and price/earnings-to-growth ratio is 1.04.